Recent Updates
Recently added Catalysts
CHRS Positive Sentiment

Coherus BioSciences Management to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Wednesday, January 3, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Coherus BioSciences, Inc. will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024. The presentation is scheduled for 9:45 a.m. Pacific Time, and will include a Q&A session accessible via a Webcast. This event is an opportunity for Coherus to showcase its developments and engage with potential investors. The webcast will remain available for replay until February 9, 2024.
Price reaction · baseline $3.14 (2024-01-02 close) · hit after-hours · clean, no other CHRS news in the window
day 0 close · peak
-3.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Coherus management will engage with investors at a prestigious conference.
  • Webcast format allows for wider accessibility and participation.
  • Presentation may lead to increased investor interest and confidence.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+136%
120-day peak, hindsight
Typical move
6.6%
average across 12 past catalysts
Cash runway
~5 mo
High dilution risk
Lead asset
CHS-0214
Phase 3 · Rheumatoid Arthritis

Full Press Release Details

REDWOOD CITY, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” Nasdaq: CHRS), today announced that senior management will present at the upcoming 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 9:45 a.m. Pacific Time. The presentation and Q&A session will be accessible via Webcast through a link posted on the Investor Events Calendar section of the Coherus website: https://investors.coherus.com/upcoming-events. This webcast will be available for replay until February 9, 2024.
Coherus Contact Information:
Jami Taylor, Head of Investor Relations
Coherus Biosciences, Inc.

Frequently Asked Questions

When will Coherus present at the J.P. Morgan Healthcare Conference?

Coherus will present on January 10, 2024, at 9:45 a.m. Pacific Time.

How can I access Coherus' presentation webcast?

The webcast can be accessed via a link on Coherus' Investor Events Calendar.

Until when will the webcast be available for replay?

The webcast will be available for replay until February 9, 2024.

Who should I contact for investor relations at Coherus?

For investor relations, contact Jami Taylor at Coherus BioSciences.

ShareAdd on Google
Tags: CHRS Viatris Investor Conferences Healthcare Coherus BioSciences J.P. Morgan healthcare conference investor relations
Last updated: Jan 3, 2024

Biotech snapshot

Cash runway
$105M liquidity · $21M/mo burn
~5 mo
High dilution risk
Lead asset
CHS-0214Phase 3
Rheumatoid Arthritis →

Catalyst track record

+136%
best trade around CHRS's most recent catalyst

Peak hindsight return over a 120-day window, across 12 tracked FDA/PDUFA catalysts for CHRS.

See every catalyst's timing & PoA →